Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

93 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Long-term efficacy and safety of Raltegravir combined with optimized background therapy in treatment-experienced patients with drug-resistant HIV infection: week 96 results of the BENCHMRK 1 and 2 Phase III trials.
Steigbigel RT, Cooper DA, Teppler H, Eron JJ, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Katlama C, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Clotet B, Zhao J, Wan H, Rhodes RR, Strohmaier KM, Barnard RJ, Isaacs RD, Nguyen BY; BENCHMRK Study Teamsa. Steigbigel RT, et al. Clin Infect Dis. 2010 Feb 15;50(4):605-12. doi: 10.1086/650002. Clin Infect Dis. 2010. PMID: 20085491 Free PMC article. Clinical Trial.
Responsiveness of muscle protein synthesis to growth hormone administration in HIV-infected individuals declines with severity of disease.
McNurlan MA, Garlick PJ, Steigbigel RT, DeCristofaro KA, Frost RA, Lang CH, Johnson RW, Santasier AM, Cabahug CJ, Fuhrer J, Gelato MC. McNurlan MA, et al. Among authors: steigbigel rt. J Clin Invest. 1997 Oct 15;100(8):2125-32. doi: 10.1172/JCI119747. J Clin Invest. 1997. PMID: 9329979 Free PMC article. Clinical Trial.
Impairment of phagosome-lysosome fusion in HIV-1-infected macrophages.
Moorjani H, Craddock BP, Morrison SA, Steigbigel RT. Moorjani H, et al. Among authors: steigbigel rt. J Acquir Immune Defic Syndr Hum Retrovirol. 1996 Sep;13(1):18-22. doi: 10.1097/00042560-199609000-00003. J Acquir Immune Defic Syndr Hum Retrovirol. 1996. PMID: 8797681
93 results